Navigation Links
Global Medical Oxygen Systems Industry
Date:9/5/2013

n Systems, Oxygen Cylinders &

Regulators and Oxygen Conserving Devices Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-24

 

Table 18: US Historic Review for Medical Oxygen Systems by

Product Segment - Oxygen Concentrators, Liquid Oxygen

Systems, Oxygen Cylinders & Regulators and Oxygen Conserving

Devices Markets Independently Analyzed with Annual Sales

Figures in US$ Thousand for Years 2004 through 2009

(includes corresponding Graph/Chart) III-25

 

Table 19: US 15-Year Perspective for Medical Oxygen Systems

by Product Segment - Percentage Breakdown of Value Sales

for Oxygen Concentrators, Liquid Oxygen Systems, Oxygen

Cylinders & Regulators and Oxygen Conserving Devices Markets

for Years 2004, 2013 & 2018 (includes corresponding

Graph/Chart) III-26

 

2. CANADA III-27

A.Market Analysis III-27

Current & Future Analysis III-27

Product Launch III-27

Strategic Corporate Development III-27

B.Market Analytics III-28

Table 20: Canadian Recent Past, Current & Future Analysis

for Medical Oxygen Systems by Product Segment - Oxygen

Concentrators, Liquid Oxygen Systems, Oxygen Cylinders &

Regulators and Oxygen Conserving Devices Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-28

 

Table 21: Canadian Historic Review for Medical Oxygen

Systems by Product Segment - Oxygen Concentrators, Liquid

Oxygen Systems, Oxygen Cylinders & Regulators and Oxygen

Conserving Devices Markets Independently Analyzed with

Annual Sales Figures in US$ Thousand for Years 2004 throu
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine technology :

1. Soligenix to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City
2. Global Intravenous Solutions (Parenteral Nutrition) Industry
3. Questcor Pharmaceuticals to Participate in Morgan Stanley Global Healthcare Conference
4. Lexicon To Present At The Morgan Stanley Global Healthcare Conference
5. Global Cardiac Medical Devices 2009-2015 - Updated Report
6. Global Cardiac Rhythm Management (CRM) Devices - Market Growth Analysis, 2009-2015
7. BioReliance Opens New U.S. Clearance Services Laboratories; Completes Global Facility Upgrade Plan
8. Isis Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference
9. Immune Pharmaceuticals Inc. Presenting At The 15th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th, 2013
10. One-Year Data From Global Atrial Fibrillation (AF) Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke
11. Auxilium Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Md. , Aug. 28, 2014 ... of novel anti-infective biologic and drug candidates targeting ... and FUJIFILM Diosynth Biotechnologies UK Limited (Fujifilm), announced ... phase of cGMP manufacturing of SYN-004, Synthetic Biologics, ... Clostridium difficile ( C. difficile ) ...
(Date:8/28/2014)... 28, 2014 Today is the official launch ... higher education, student and pharmaceutical organizations that will work ... ADHD prescription stimulant medication. The Coalition will initially focus ... reported rates of nonmedical use vary, a 2013 study ... 1 of college students reported nonmedical use of ...
(Date:8/27/2014)... 27, 2014 TWi Pharmaceuticals, Inc. (4180.TT) today ... the United States Food and Drug Administration (FDA) ... megestrol acetate 125mg/ml oral suspension, the generic equivalent ... first-to-file and under Hatch Waxman rules, it will ...  TWi has completed the pre-launch preparation of the ...
Breaking Medicine Technology:Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 2Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 3Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 4Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 5New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 2New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 3New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 4New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 5New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 6TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2
... -- American Oriental Bioengineering, Inc. (NYSE: AOB ) ... (the "NYSE") has notified the Company that it is not ... to timely file its Annual Report on Form 10-K with ... rules, when a Company does not comply with annual report ...
...  In conjunction with its first quarter 2012 earnings release (expected to be ... CVD ) is pleased to invite you to listen to its ... on Thursday, May 3, 2012 at 9:00 a.m. ET. , ... and Slide Presentation , , , , When: , , , ...
Cached Medicine Technology:American Oriental Bioengineering Inc. Receives NYSE Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard 2
(Date:8/28/2014)... Mass., (PRWEB) August 28, 2014 BCC ... SURGICAL NAVIGATION SYSTEMS: TECHNOLOGIES AND GLOBAL MARKETS , ... at $419.7 million in 2013. Driven by the need ... by medical tourism in emerging geographies, the market is ... annual growth rate (CAGR) of 8.5% from 2013 through ...
(Date:8/28/2014)... Albany, New York (PRWEB) August 28, 2014 ... is currently perceived with great interest among other healthcare ... due to the high demand in vaccine with respect ... also highly in demand due to an improved understanding ... individuals across the United States. It has led to ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Canadian Linen ... company in North America, today announced the launch of ... makes doing business with Canadian Linen even easier and ... customers to access account information online and better communicate ... portal include the ability to:, , ...
(Date:8/28/2014)... AmeriPride Services, a leading textile services ... launch of its new Customer Portal, an online resource ... more convenient for customers. The industry-leading digital tool allows ... with the company. , Features of the new customer ... Access, download and pay bills online , ...
(Date:8/28/2014)... August 28, 2014 Parker Waichman LLP, ... many years fighting to ensure that the heroes of ... provide coverage to WTC victims who developed 9/11-related cancer ... Government Accountability Office (GAO). According to a statement issued ... the report is entitled “World Trade Center Health Program: ...
Breaking Medicine News(10 mins):Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 3Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 3Health News:Canadian Linen and Uniform Service Launches New Customer Portal 2Health News:Canadian Linen and Uniform Service Launches New Customer Portal 3Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 2Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 3
... New research challenges the previously held belief that infants' ... new study finds the brain's left hemisphere plays the ... immediately after birth. ,Researchers are using functional ... activity in response to speech. They say this is ...
... try to avoid getting it, but researchers say common cold ... genetically engineer the common cold virus so that //it kills ... They did this by modifying one gene, so the virus ... the activity of another gene to ensure that the virus ...
... Government guidelines on the treatment of asthma have long ... for people with persistent forms of the condition.But reports ... people -- including parents of asthmatic children -- to ... growth retardation in children, weak bones in children and ...
... therapeutic option for patients with complicated type 1 diabetes, ... // Now, a new study finds ... worse survival than patients on the transplant waiting list ... Association supports a pancreatic transplant for patients who have ...
... a vaccine made from the common cold virus may induce ... the Centers for Disease Control and Prevention injected six monkeys ... parts of the SARS coronavirus. A new form of the ... were given a second vaccine 28 days later, and researchers ...
... women with diabetes have a higher risk of depression., ... 60 and 79. The participants were divided //into two ... the second included those without diabetes. Women who did ... groups, based on their levels of insulin resistance. ...
Cached Medicine News:Health News:New Technique to Study Infants Brain. 2Health News:Benefits and Risks of Asthma Treatment Questioned 2Health News:Pancreas Transplant for Diabetics 2
... GV is a sterile, non-pyrogenic, transparent ... noninflammatory, high molecular weight (average = ... hyaluronate. Healon GV contains 14 mg/mL ... a physiological sodium chloride-phosphate buffer (pH ...
... PROVISC ophthalmic viscosurgical device ... is characterized by high molecular ... surface tension. It provides excellent ... and is easily removed. It ...
... a product comes along that forever raises ... category. The new StealthStation TREON plus Treatment ... Built on the phenomenal success of the ... system in the worldthe new TREON plus ...
... the DigiCat Imager ("DCI") to provide rapid, ... The DCI can measure the cataract and ... objective, appropriate and timely surgical decision can ... technology is especially useful in todays healthcare ...
Medicine Products: